Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry


Verheugt F. W. A., Gao H., Al Mahmeed W., Ambrosio G., Angchaisuksiri P., Atar D., ...More

EUROPEAN HEART JOURNAL, vol.39, no.6, pp.464-473, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 39 Issue: 6
  • Publication Date: 2018
  • Doi Number: 10.1093/eurheartj/ehx730
  • Journal Name: EUROPEAN HEART JOURNAL
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.464-473
  • Istanbul University Affiliated: No

Abstract

Aims Current atrial fibrillation (AF) guidelines discourage antiplatelet (AP) monotherapy as alternative to anticoagulants (ACs). Why AP only is still used is largely unknown.